Diffusion alterations associated with Parkinson's disease symptomatology: A review of the literature.
about
Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).Diffusion tensor imaging in Parkinson's disease: Review and meta-analysisThe role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.Antioxidant and neuroprotector effect of Lepidium meyenii (maca) methanol leaf extract against 6-hydroxy dopamine (6-OHDA)-induced toxicity in PC12 cells.Exploring white matter microstructure and olfaction dysfunction in early parkinson disease: diffusion MRI reveals new insight.Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey.Does apolipoprotein A1 predict microstructural changes in subgenual cingulum in early Parkinson?A meta-analysis of diffusion tensor imaging of substantia nigra in patients with Parkinson's disease.White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Impulse Control Disorders.Gray/White Matter Contrast in Parkinson's Disease.Gait Asymmetry in People With Parkinson's Disease Is Linked to Reduced Integrity of Callosal Sensorimotor Regions.Microstructural Changes in Patients With Parkinson's Disease Comorbid With REM Sleep Behaviour Disorder and Depressive Symptoms.Progressive Decline in Gray and White Matter Integrity in Parkinson's Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging DataAutonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson's diseaseReduced occipital GABA in Parkinson disease with visual hallucinationsSerum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure
P2860
Q33831798-312A9B16-008A-409B-A06C-474D5418F623Q38647751-D8A6E138-B777-48C3-822B-0EDBF7440312Q39192172-9DD6F32C-4779-489F-BEFF-C50B58BD5E3AQ46441522-FAB0BF77-F6C1-4DAE-935D-AF0D560C18B1Q47218321-C475B0AB-C70F-4D75-8B45-106C9AFB70A4Q47998172-928EE523-BE9D-4A5B-81B5-AD31F84CEE04Q48320628-489764F8-6506-4DCF-A788-2E1D30D2876EQ49638209-64E4C0B0-8A95-4002-B9A8-4B72F307FBE6Q52319579-BCA0BFE9-E5DD-43A2-82CA-345E3712AE70Q55071203-A2A9BACA-B300-4C30-A525-C0E462D10E30Q55236052-178B0599-09AF-4AA5-BD03-B72BC37F23F4Q55664351-03317C64-E532-4994-A337-1C054E139A76Q57817384-E3C788A1-8440-444B-AE7F-685266AD8F57Q58743454-2491FFAF-2777-48A0-9CBC-C6EF65D4BBC1Q58780869-A7E4620F-6F6B-40B8-9ABF-ACEA2377538CQ59137487-B2E09D63-C245-4974-8F77-344980BB5F95
P2860
Diffusion alterations associated with Parkinson's disease symptomatology: A review of the literature.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Diffusion alterations associat ...... y: A review of the literature.
@en
type
label
Diffusion alterations associat ...... y: A review of the literature.
@en
prefLabel
Diffusion alterations associat ...... y: A review of the literature.
@en
P50
P1476
Diffusion alterations associat ...... y: A review of the literature.
@en
P2093
Kaylena A Ehgoetz Martens
P356
10.1016/J.PARKRELDIS.2016.09.026
P50
P577
2016-09-28T00:00:00Z